Balchem Co. (NASDAQ:BCPC) Shares Acquired by SG Americas Securities LLC

Posted by Defense World Staff on Jul 22nd, 2023

SG Americas Securities LLC grew its holdings in Balchem Co. (NASDAQ:BCPC – Free Report) by 41.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 16,439 shares of the basic materials company’s stock after purchasing an additional 4,818 shares during the quarter. SG Americas Securities LLC owned approximately 0.05% of Balchem worth $2,079,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the business. BlackRock Inc. grew its position in shares of Balchem by 1.0% in the first quarter. BlackRock Inc. now owns 4,890,972 shares of the basic materials company’s stock valued at $668,595,000 after purchasing an additional 46,959 shares during the last quarter. Vanguard Group Inc. boosted its position in Balchem by 7.3% during the third quarter. Vanguard Group Inc. now owns 3,862,027 shares of the basic materials company’s stock worth $469,545,000 after acquiring an additional 261,534 shares during the last quarter. State Street Corp boosted its position in Balchem by 1.7% during the third quarter. State Street Corp now owns 1,067,814 shares of the basic materials company’s stock worth $129,825,000 after acquiring an additional 17,532 shares during the last quarter. Conestoga Capital Advisors LLC boosted its position in Balchem by 0.9% during the first quarter. Conestoga Capital Advisors LLC now owns 1,049,446 shares of the basic materials company’s stock worth $132,734,000 after acquiring an additional 8,868 shares during the last quarter. Finally, Geneva Capital Management LLC boosted its position in Balchem by 3.3% during the fourth quarter. Geneva Capital Management LLC now owns 750,324 shares of the basic materials company’s stock worth $91,622,000 after acquiring an additional 23,776 shares during the last quarter. 87.51% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Balchem news, SVP Michael Robert Sestrick sold 2,300 shares of the stock in a transaction that occurred on Tuesday, May 2nd. The shares were sold at an average price of $130.36, for a total transaction of $299,828.00. Following the transaction, the senior vice president now owns 5,424 shares of the company’s stock, valued at $707,072.64. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 1.77% of the stock is currently owned by insiders.

Balchem Stock Performance

NASDAQ:BCPC opened at $131.59 on Friday. The company has a quick ratio of 1.81, a current ratio of 2.88 and a debt-to-equity ratio of 0.48. The company has a market cap of $4.24 billion, a P/E ratio of 43.00 and a beta of 0.71. Balchem Co. has a fifty-two week low of $116.68 and a fifty-two week high of $143.88. The firm’s 50 day moving average is $130.17 and its two-hundred day moving average is $129.28.

Balchem (NASDAQ:BCPC – Get Free Report) last posted its quarterly earnings results on Friday, April 28th. The basic materials company reported $0.70 earnings per share for the quarter, missing analysts’ consensus estimates of $0.78 by ($0.08). The company had revenue of $232.54 million for the quarter, compared to analysts’ expectations of $232.00 million. Balchem had a return on equity of 10.69% and a net margin of 10.48%. During the same period in the prior year, the business earned $0.89 EPS. Analysts expect that Balchem Co. will post 3.41 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on BCPC shares. HC Wainwright raised their target price on shares of Balchem from $140.00 to $150.00 in a research report on Monday, June 5th. StockNews.com started coverage on shares of Balchem in a research report on Thursday, May 18th. They set a “hold” rating on the stock.

Balchem Company Profile

(Free Report)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.